期刊文献+

318例骨科Ⅰ类切口手术围术期预防性应用抗菌药物的合理性分析 被引量:13

Analysis on Application Rationality of Prophylactic Antibiotics in 318 Orthopedics Patients with Type Ⅰ Incision During Perioperative Period
在线阅读 下载PDF
导出
摘要 目的:了解骨科Ⅰ类切口手术围术期预防性应用抗菌药物的合理性情况,为规范围术期预防性用药提供参考。方法:采用回顾性调查分析方法,抽取南昌市第三医院(以下简称"我院")318例骨科Ⅰ类切口手术患者的病历资料,对预防性应用抗菌药物的合理性进行统计分析。结果:我院骨科Ⅰ类切口手术围术期抗菌药物预防性使用率为90.88%(289/318)。289例预防性用药患者中,术前2 h给药率为99.31%(287/289);抗菌药物选择合理率为98.96%(286/289);用药疗程合理率为83.04%(240/289);预防性用药时间>48 h患者所占比例为14.53%(42/289);手术时间>3 h者63例、失血量>1 500 ml者6例(其中上述2种情况同时出现的有2例),仅13例患者术中追加抗菌药物。结论:我院骨科Ⅰ类切口手术围术期抗菌药物预防性使用率较高,预防性用药时间>48 h患者所占比例也较高,术中追加率偏低,有待今后持续改进。 OBJECTIVE: To investigate the application rationality of prophylactic antibiotics in orthopedics patients with type Ⅰ incision,so as to provide reference for the standardization of prophylactic application during perioperative period. METHODS: Retrospective analysis was adopted,the medical records of 318 orthopedics patients with type Ⅰincision were extracted from the Third Hospital of Nanchang( hereinafter referred to as "our hospital"),statistical analysis was conducted on the application rationality of prophylactic antibiotics. RESULTS: The prophylactic application rate of antibiotics in type Ⅰ incision was 90. 88%( 289 /318). Of the 298 patients with prophylactic antibiotics,the rate of administration before operation of 2 h was 99. 31%( 287 /289),the rational rate of antibiotics selection was 98. 96%( 286 /289),and the rational rate of treatment course was 83. 04%( 240 /289). The percentage of drug duration more than 48 h were 14. 53%( 42 /289). Meanwhile,there were 63 cases with operative time more than 3 h,6 cases with blood loss more than 1 500 ml( 2 cases had both situations),and only 13 cases had the addition of antibiotics during the operation. CONCLUSIONS: The prophylactic application rate of antibiotics in type Ⅰ incision of our hospital is relatively high as well as the percentage of drug duration more than 48h; yet the additional rate during operation is relatively low; which still needs to be institutionalized,long-term oriented.
出处 《中国医院用药评价与分析》 2016年第7期974-976,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 骨科 Ⅰ类切口手术 围术期 预防性用药 合理用药 Orthopedics Type Ⅰ incision Perioperative period Prophylactic application Rational drug use
作者简介 副主任药师,硕士。研究方向:临床药学。E—mail:mlsxnc@yeah.net
  • 相关文献

参考文献13

  • 1卓霞,阚燕,闽鹏.骨科Ⅰ类切口手术抗菌药物预防使用干预效果研究[J].中国抗生素杂志,2013,38(10):799-800. 被引量:35
  • 2王玉,薛苏冬,张茜,曹成.干预前后骨科Ⅰ类切口手术围术期预防性应用抗菌药物对比分析[J].中国医院用药评价与分析,2013,13(2):178-181. 被引量:15
  • 3李小梅,郑咏池,王洪贵,任强.专项整治前后我院骨科Ⅰ类切口抗菌药物使用情况分析[J].中国药业,2013,22(2):40-41. 被引量:7
  • 4Landes G,Harris PG,Lemaine V,et al.Prevention of surgical site infection and appropriateness of antibiotic prescribing habits in plastic surgery[J].J Plast Reconstr Aesthet Surg,2008,61(11):1347-1356.
  • 5Alexadner JW,Solomkin JS,Edwards MJ.Updated recommendations for control of surgical site infections[J].Ann Surg,2011,253(6):1082-1093.
  • 6Scher KS.Studies on the duration of antibiotic administration for surgical prophylaxis[J].Am Srug,1997,63(1):59-62.
  • 7Wittmann DH,Schein M.Let us shorten antibiotic prophylaxis and therapy in surgery[J].Am J Surg,1996,172(6A):26S-32S.
  • 8Gillespie WJ.Prevention and management of infection after total joint replacement[J].Clin Infect Dis,1997,25(6):1310-1317.
  • 9Hirschmann JV.Antimicrobial prophylaxis in dermatologic surgery[J].Cutis,2007,79(6 Suppl):43-51.
  • 10Rosenthal VD,Maki DG,Jamulitrat S,et al.International Nosocomial Infection Control Consortium(INICC)report,data summary for 2003-2008,issued June 2009[J].Am J Infect Control,2010,38(2):95-104.

二级参考文献27

  • 1张志清.国内抗菌药物应用现状及实施抗菌药物合理应用干预的可行性与难点[J].中国药房,2004,15(12):708-710. 被引量:111
  • 2黄少娟,潘燕青,郭少英.术前备皮法的改良发展趋势[J].南方护理学报,2005,12(3):19-20. 被引量:25
  • 3无.围手术期预防应用抗菌药物指南[J].中华外科杂志,2006,44(23):1594-1596. 被引量:846
  • 4卫生部.抗菌药物临床应用指导原则[S].卫医发[2004]285号.
  • 5卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知.卫办医政发[2009]38号.
  • 6卫生部医政司.《2011年抗菌药物临床应用专项整治活动方案》(卫办医政发(20l1)56号).
  • 7卫生部,国家中医药管理局总后卫生部.《抗菌药物临床应用指导原则》[S],卫医发[2004]285号.
  • 8Haaker R, Senge A, Kramer J. Osteomyelitis after endoprostheses[J]. Orthopade, 2004, 33(4): 431-438.
  • 9de Jong P T, van der Vis H M, de Man F H. Weber rotation total hip replacement: a prospective 5 to 20-year follow up study[J]. Clin Orthop, 2004, (419): 107-114.
  • 10Simmons M. Pre-operative skin preparation[J]. ProfNurse, 1998, 13(7): 446-447.

共引文献59

同被引文献117

引证文献13

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部